In a recent study in breast cancer, there was a role of Bcl-xL in cell migration and mitochondrial metabolism, favouring the onset and dissemination of metastases, prompting for modulation of the VDAC1/Bcl-xL interaction as a promising target for anti-tumor therapy in the context of metastatic breast cancer [34]. The gene discussed is BCL2L1; the disease is breast cancer.